Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)
Completed · Phase 3
Conditions studied: Breast Cancer
In brief
The primary objective of this study is to compare the efficacy of sacituzumab govitecan to the treatment of physician's choice (TPC) as measured by independently-reviewed Independent Review Committee (IRC) progression-free survival (PFS) in participants with locally advanced or metastatic triple-negative breast cancer (TNBC) previously treated with at least two systemic chemotherapy regimens for unresectable, locally advanced or metastatic disease, and without brain metastasis at baseline.
Key facts
- Study ID
- NCT02574455
- Run by
- Gilead Sciences
- People needed
- 529
- Starts
- 2017-11-07
- Expected to finish
- 2020-12-08
- Last updated by the study team
- 2022-06-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Souther Cancer Center, 3719 Dauphin St., 5 Floor — Mobile, Alabama, United States
- Southern Cancer Center, 3 Mobile Infirmary Circle — Mobile, Alabama, United States
- Southern Cancer Center, 6701 Airport Blvd., Bldg B, Terace Level — Mobile, Alabama, United States
- Mayo Clinic Hospital — Phoenix, Arizona, United States
- Mayo Clinic Hospital — Scottsdale, Arizona, United States
- UCLA Jonsson Comprehensive Cancer Center, 1411 S. Garfield Ave Suite 200 — Alhambra, California, United States
- UCLA Jonsson Comprehensive Cancer Center, 201. S. Buena Vista St Suite 200 — Burbank, California, United States
- UCLA Jonsson Comprehensive Cancer Center — Laguna Hills, California, United States
- UCLA Jonsson Comprehensive Cancer Center, 200 UCLA Medical Plaza — Los Angeles, California, United States
- UCLA Jonsson Comprehensive Cancer Center, 625 South Fair Oaks Avenue Suite 320 — Pasadena, California, United States
- University of California, San Francisco (UCSF) - Innovation, Technology & Alliances, 1600 Divisadero Street — San Francisco, California, United States
- UCLA Jonsson Comprehensive Cancer Center, 2020 Santa Monica Boulevard — Santa Monica, California, United States
- Rocky Mountain Cancer Centers, 1700 South Potomac Street — Aurora, Colorado, United States
- University of Colorado Hospital - Anschutz Cancer Pavilion, 1665 Aurora Court — Aurora, Colorado, United States
- Rocky Mountain Cancer Centers, 4715 Arapahoe Ave — Boulder, Colorado, United States
- Rocky Mountain Cancer Centers, 2312 N. Nevada Avenue, Suite 400 — Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers, 1800 Williams St. — Denver, Colorado, United States
- Rocky Mountain Cancer Centers, 4700 E. Hale Parkway, Suite 400 — Denver, Colorado, United States
- Rocky Mountain Cancer Centers, 499 E Hampden Ave Suite 450 — Englewood, Colorado, United States
- Rocky Mountain Cancer Centers, 11750 West 2nd Place, Suite 1-100 — Lakewood, Colorado, United States
- Rocky Mountain Cancer Centers, 22 West Dry Creek Circle — Littleton, Colorado, United States
- Rocky Mountain Cancer Centers, 10103 Ridge Gate Parkway, Suite G-01 — Lone Tree, Colorado, United States
- Rocky Mountain Cancer Centers, 2030 W Mountain View Avenue, Ste. 210 — Longmont, Colorado, United States
- Rocky Mountain Cancer Centers, 9397 Crown Crest Blvd., Suite 421 — Parker, Colorado, United States
- Southern Cancer Center, 29653 Anchor Cross Blvd — Daphne, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.